Submitted by Anonymous (not verified) on 1 December 2025 - 10:30
Human medicines European public assessment report (EPAR): Dupixent, dupilumab, Date of authorisation: 26/09/2017, Revision: 45, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Dupixent, dupilumab, Date of authorisation: 26/09/2017, Revision: 45, Status: Authorised